More in detail, the estrogen E2 was found to increase the expression of NRF2-dependent antioxidant genes not only in MCF-7 breast cancer cells [245] but also in normal or malignant BRCA1-deficient cells through the activation of the PI3K/GSK3β pathway [246]. Here, NFE2L2 is linked to breast cancer.